Professor Augustinus Bader

Augustinus Bader

Univ. Prof. Dr. Med., Adjunct Prof. (MIPT)

Professor Augustinus Bader is a globally recognized biomedical scientist and physician and one of the foremost experts in the field of stem cell biology and regenerative medicine.

In a career that has spanned the globe, the German-born Professor has spent over 30 years researching and developing technologies that activate and harness the human body's capacity to heal, with a focus on the reawakening of cells that become dormant due to aging or trauma. In 2008 he developed a groundbreaking Wound Gel that heals severe skin traumas without the need for surgery or skin grafts. It is this revolutionary technique that inspired Augustinus Bader skincare.

Professor Bader is currently the director of Cell Techniques and Applied Stem Cell Biology at The University of Leipzig, in Leipzig, Germany where he lives with his family.


Selected Positions and Publications

  • Director and Professor of Applied Stem Cell Biology and Cell Technology at the University of Leipzig in Germany
  • Co-founder, together with Charles Rosier, of AC THERAPEUTICS LTD
  • Founder of the International World Congress on Regenerative Medicine in Leipzig.
  • President of the World Federation and World Virtual Institute of Preventive & Regenerative Medicine.
  • Board Member of the European Tissue Engineering Society (ETES).
  • Governor of the European Society for Artificial Organs (ESAO)
  • 2002 - 2006 - at the Danube University Krems, Austria
  • 2008 - Technical Faculty of the Friedrich Alexander University of Erlangen- Nürnberg, German
  • 2011 – 2013 at the Dongseo University, Korea
  • 2013 - 2018 Adjunct Professor at Moscow Institute of Physics and Technology (MIPT) Department of Biological and Medicinal

By the Numbers


Prestigious Scientific Awards


Years of research


Peer-reviewed papers


Patents in his field


Lectures given internationally


Early on in his medical studies, Professor Bader traveled to Shanghai, China to work with burn victims at the Ruijin Hospital's Burn Center. It was here he first witnessed the immense trauma, suffering, and accompanying scar formation caused by burn injuries, especially in cases involving children – who usually require multiple difficult and painful surgeries to remove thick scar tissue that would otherwise cripple their growth development.

The need to eliminate this kind of life-long suffering later took him back to Germany, where he trained in the field of clinical organ transplant with pioneer Professor Pichlmayr - studying organ failure, traumatic wounds and furthering his research on the body's self-healing capabilities.

These experiences, his background as a surgeon, and his specialization in Medical Biotechnology drove Professor Bader to spend decades researching a treatment that would provide scar-free healing, culminating in 2008 with his development of a groundbreaking Wound Gel for skin regeneration.

The Breakthrough

In 2008, Professor Bader developed a groundbreaking Wound Gel that promotes the natural self-repair of traumatic wounds at a cellular level. From diabetic wounds to third-degree burns, the Wound Gel eliminates the need for surgery, skin grafts, or scar revision, and minimizes opportunistic infections that can create a circle of trauma for the suffering patients.

The Wound Gel functions by carrying a set of healing signals to the site of an injury, which, in turn, catalyzes a response from damaged skin cells and facilitates an expedited, automated restoration process. Professor Bader works with a select group of medical experts to develop ways to apply his breakthrough regenerative therapies in clinical practice.


The Blue Bottle Era

Backed by over 30 years of research in cellular repair and his deep understanding of stem cell biology, tissue engineering and regenerative medicine, Professor Bader has developed the patented technology TFC8® - the renewing complex present in Augustinus Bader skincare line.

Launched in 2018, Augustinus Bader is a premium, science-led skincare line backed by the highest caliber of applied science in the industry.

Duration: 30s

Career & Awards

  • .1992 - Renate and Hans Lettre recognition award of the German section of the European Tissue Culture Society.
  • 1993 - Research prize of the German Ministry of Health 1993 for the development of alternative methods for animal experiments (animal welfare).
  • 1995 - Best Paper Award of the American Society for Pharmacology and Experimental Therapeutics.
  • 1996 - The Felix Wankel Animal-Welfare-Research-Award of the German Ministry of Health for the development of alternative methods for animal experiments.
  • 1996 - First Poster Prizee of the German Society for Clinical Pharmacology, Dresden.
  • 1997 - Renate and Hans Lettre recognition award of the German section of the European Tissue Culture Society.
  • 1997 - Second Poster Prize of the German Society for Cardiovascular Surgery, Tübingen.
  • 1998 - First Prize at The Idea Competition of German Air and Space Agency (DLR of the German Ministry of Education and Research, BMBF) 1998.
  • 1999 - The Hancock prize of the German Society for Cardiovascular Surgery in 1999.
  • 1999 - Poster prize at the International Congress of Artificial Organs, Edinburgh, ”Tissue Engineering of Heart Valves.“
  • 2010 The Cicatrix Study Award 2010. The was Europe’s largest scientific prize, awarded for his work in the development of a therapeutic method to prevent scar formation following severe thermal injuries such as burns.
1981 - 1987
  • 1981 - 1982 - Studied at Università Degli Studi, Gabriele D'Annunzio, Chieti, Italy and Wurzburg, Julius Maximilians Universität in Germany.
  • 1982 - 1987 - Studied Human Medicine Wurzburg, Julius Maximilians Universität in Germany.
  • 1986 - Studied at Shanghai Second Medical College, Rui Jin Hospital Burns Institute in China.
  • 1987 - Studied Cardiac Surgery at Harvard Medical School and Internal Medicine & General Surgery at Wright State University in the United States.
1987 - 1992
  • 1987 - 1988 - Studied Neurology at Bern, Inselspital in Switzerland.
  • 1987 - Completed Degree in Human Medicine from the Universität Würzburg.
  • 1988 - Acquired his Medical licence.
  • 1989 - 1990 - Postdoctoral research fellow at Harvard Medical School, General Hospital and Shriners Hospital for Crippled Children, Burns Institute.
1990 - 2002
  • 1990 - 2001 - Held positions at the Hannover Medical School (known for stem cell research and regenerative medicine)
  • - Specializations included: Transplant immunology and surgery, Head of the Research Group Drug Metabolism and Bioartificial Liver, Biotechnology and Artificial Organs.
  • 2001 - 2002 - Became the Associate Professor for Tissue Engineering Eberhard Karls at the University of Tuebingen
1993 - 1999
  • 1996 - Gained his State Board Certification in Pharmacology and Toxicology.
  • 1997 - Renate and Hans Lettre recognition award of the German section of the European Tissue Culture Society.
  • 1998 - Became the first professor for Tissue Engineering in Germany at the University of Tüebingen, Germany.
  • 1999 - Habilitation: Privatdozent (PD) in Experimental Surgery (official teaching affiliation in this field associated with the Medical School of Hannover, Germany).
2003 - 2008
  • 2003 - Present - Full Professor for stem cell biology and cell technologies and first chair holder in stem cell biology at University of Leipzig.
  • 2007 - Present - Founded private R&D institution, Bionethos Innovation GmbH, to continue work in regenerative medical therapy systems and translate for individual patient’s application.
  • 2008 - First medical breakthrough came in the form of a medical-grade Wound Gel.
2009 - Present
  • 2009 - Co-founded the World Virtual Institute and World Federation Preventive & Regenerative Medicines (WI-WF-PYRAMED).
  • 2016 - Successful clinical healing of burns, scalds, chronic ulcers, tendon and cartilage injuries, bone defects, and nerve degeneration were achieved.
  • 2017 – Present - Co-Founded with investor Charles Rosier both ASC Skin Therapeutics Ltd to develop the current prototype of the Wound Gel into a medical-grade therapy and focus on further regenerative therapies, and ASC Regenity Ltd, for the development of Augustinus Bader skincare with the aim of funding research and clinical trials in regenerative therapies.
  • 2018 - Augustinus Bader skincare launched hero products The Cream and The Rich Cream